Low-grade endometrial stromal sarcoma: A single center's experience with 22 cases

International Journal of Gynecological Cancer

Volumn 18, Issue 5, 2008, Pages 1084-1089

  Kim, W Y ^a   Lee, J W ^a   Choi, C H ^a   Kang, H ^a   Kim, T J ^a   Kim, B G ^a   Lee, J H ^a   Bae, D S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Adjuvant treatment; BSO; LGESS; Recurrence

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOMETRIUM SARCOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LIVER CANCER; LUNG CANCER; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; STROMA CELL; SYMPTOMATOLOGY; VAGINA BLEEDING;

ADULT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SARCOMA, ENDOMETRIAL STROMAL; SURVIVAL RATE;

EID: 51749120775     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01159.x     Document Type: Article

References (35)

1. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 1966 19 : 755 66.
2. Bodner K, Bodner-Adler B, Obermair A et al. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001 81 : 160 5.
3. Kahanpaa KV, Wahlstrom T, Grohn P, Heinonen E, Nieminen U, Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 1986 67 : 417 24.
4. Taina E, Maenpaa J, Erkkola R, Ikkala J, Soderstrom O, Viitanen A. Endometrial stromal sarcoma: a report of nine cases. Gynecol Oncol 1989 32 : 156 62.
5. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr. Treatment of endometrial stromal tumors. Gynecol Oncol 1990 36 : 60 5.
6. De Fusco PA, Gaffey TA, Malkasian GD Jr., Long HJ, Cha SS. Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945-1980. Gynecol Oncol 1989 35 : 8 14.
7. Evans HL. Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma. Cancer 1982 50 : 2170 82.
8. Hart WR, Yoonessi M. Endometrial stromatosis of the uterus. Obstet Gynecol 1977 49 : 393 403.
9. Gadducci A, Sartori E, Landoni F et al. Endometrial stromal sarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996 63 : 247 53.
10. Leunen M, Breugelmans M, De Sutter P, Bourgain C, Amy JJ. Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. Gynecol Oncol 2004 95 : 769 71.
11. Scribner DR Jr., Walker JL. Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace. Gynecol Oncol 1998 71 : 458 60.
12. Haberal A, Kayikcioglu F, Boran N, Caliskan E, Ozgul N, Kose MF. Endometrial stromal sarcoma of the uterus: analysis of 25 patients. Eur J Obstet Gynecol Reprod Biol 2003 109 : 209 13.
13. Piver MS, Rutledge FN, Copeland L, Webster K, Blumenson L, Suh O. Uterine endolymphatic stromal myosis: a collaborative study. Obstet Gynecol 1984 64 : 173 8.
14. Inayama Y, Shoji A, Odagiri S et al. Detection of pulmonary metastasis of low-grade endometrial stromal sarcoma 25 years after hysterectomy. Pathol Res Pract 2000 196 : 129 34.
15. Satoh Y, Ishikawa Y, Miyoshi T, Mukai H, Okumura S, Nakagawa K. Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy. Virchows Arch 2003 442 : 173 8.
16. Spano JP, Soria JC, Kambouchner M et al. Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol 2003 20 : 87 93.
17. Tabata T, Takeshima N, Hirai Y, Hasumi K. Low-grade endometrial stromal sarcoma with cardiovascular involvement - a report of three cases. Gynecol Oncol 1999 75 : 495 8.
18. Liokumovich P, Goldberg I, Davidson B et al. Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis. J Clin Pathol 1999 52 : 198 202.
19. Stadsvold JL, Molpus KL, Baker JJ, Michael K, Remmenga SW. Conservative management of a myxoid endometrial stromal sarcoma in a 16-year-old nulliparous woman. Gynecol Oncol 2005 99 : 243 5.
20. Berkowitz RS, Goldstein GD. Uterine cancer. In : Berek JS, Hacker NE, eds. Practical gynecologic oncology, 4th edn. Williams & Wilkins, 2005 : 431 2.
21. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma. Gynecol Oncol 1996 62 : 254 9.
22. Schwartz SM, Thomas DB. A case-control study of risk factors for sarcomas of the uterus. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer 1989 64 : 2487 92.
23. Li AJ, Giuntoli RL II., Drake R et al. Ovarian preservation in stage I low-grade endometrial stromal sarcomas. Obstet Gynecol 2005 106 : 1304 8.
24. O'Meara AT. Uterine sarcomas: have we made any progress? Curr Opin Obstet Gynecol 2004 16 : 1 4.
25. Omura GA, Blessing JA, Major F et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol 1985 3 : 1240 5.
26. Antman KH, Ryan L, Elias A, Sherman D, Grier HE. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol 1989 7 : 126 31.
27. Antman K, Crowley J, Balcerzak SP et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993 11 : 1276 85.
28. Edmonson JH, Ryan LM, Blum RH et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993 11 : 1269 75.
29. Santoro A, Tursz T, Mouridsen H et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995 13 : 1537 45.
30. Mansi JL, Ramachandra S, Wiltshaw E, Fisher C. Endometrial stromal sarcomas. Gynecol Oncol 1990 36 : 113 8.
31. Weitmann HD, Knocke TH, Kucera H, Potter R. Radiation therapy in the treatment of endometrial stromal sarcoma. Int J Radiat Oncol Biol Phys 2001 49 : 739 48.
32. Reed NS. Uterine sarcomas - the biggest challenge? Clin Oncol (R Coll Radiol) 2002 14 : 50 3.
33. Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I. The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecol Oncol 2003 90 : 37 43.
34. Gloor E, Schnyder P, Cikes M et al. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy. Cancer 1982 50 : 1888 93.
35. Styron SL, Burke TW, Linville WK. Low-grade endometrial stromal sarcoma recurring over three decades. Gynecol Oncol 1989 35 : 275 8.